BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

  • Steen Lindkær-Jensen, Stig Larsen, Kritiya Butthongkomvong, Alexey Manikas, Ekaterina Trishkina, Elena Poddubudkaya, Marina Matrosova, Vichien Srimuninnimit
  • Breast Cancer Targets and Therapy, November 2014, Taylor & Francis
  • DOI: 10.2147/bctt.s71781

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Mrs Elena Vladimirovna Poddubskaya, Stig Larsen, and Kritiya Butthongkomvong